CART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (Q62810875)
Jump to navigation
Jump to search
clinical trial
Language | Label | Description | Also known as |
---|---|---|---|
English | CART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) |
clinical trial |
Statements
CD19-Targeted CAR-T in Treating Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (English)
0 references
1 March 2018
0 references
1 March 2019
0 references
10
0 references
14 year
0 references
75 year
0 references